Assistant ProfessorMedicine Attending Physician, University of Washington Medical CenterFaculty Information Biography Neal Chatterjee, MD, MSc is a cardiologist and cardiac electrophysiologist at the University of Washington Medical Center and an assistant professor of Medicine at the University of Washington. Dr. Chatterjee’s clinical interests focus on catheter ablation of cardiac arrhythmias, particularly ventricular tachycardia, atrial fibrillation, and other supraventricular tachycardias (SVTs). Dr. Chatterjee values understanding each patient’s goals in order to create an active partnership with his patients and deliver the best care possible. Dr. Chatterjee received his medical degree from Harvard Medical School. He then completed his internal medicine residency and fellowships in cardiology and cardiac electrophysiology at Massachusetts General Hospital/Harvard Medical School. He also earned a Master of Science in Epidemiology from the Harvard School of Public Health. Dr. Chatterjee is an active clinical investigator with a research focus on the prevention and treatment of sudden cardiac death. Personal Interests Dr. Chatterjee enjoys spending time with his family, reading a great book, and hiking. Education & Training: Fellowship, 2019, ElectrophysiologyMassachusetts General HospitalBoston, MA2019 MasterHarvard School of Public HealthBoston, MA2017 Fellowship, 2017, Cardiovascular DiseaseMassachusetts General HospitalBoston, MA2017 Fellowship, 2013, Internal MedicineMassachusetts General HospitalBoston, MA2013 Medical EducationHarvard Medical SchoolBoston, MA2010 Contact Mailing Address: University of Washington Medical Center 1959 NE Pacific Street Box 356422 Seattle, WA 98195-6422 Non-Clinical Administrative Support Contact: uwcard@cardiology.washington.edu For appointments or other clinical matters, please contact the Heart Institute. Publications PubMed: PubMed BibliographyMy NCBI: My NCBI BibliographyPublications: Chatterjee NA, Chae CU, Kim E, Moorthy MV, Conen D, Sandhu RK, Cook NR, Lee IM, Albert CM Modifiable Risk Factors for Incident Heart Failure in Atrial Fibrillation. JACC. Heart failure 2017 Aug; 5; 8; 552-560; Chatterjee NA, He Y, Keating NL Racial differences in breast cancer stage at diagnosis in the mammography era. American journal of public health 2013 Jan; 103; 1; 170-6; Chatterjee NA, Upadhyay GA, Ellenbogen KA, Hayes DL, Singh JP Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis of biventricular vs. right ventricular pacing mode. European journal of heart failure 2012 Jun; 14; 6; 661-7; Chatterjee NA, Upadhyay GA, Ellenbogen KA, McAlister FA, Choudhry NK, Singh JP Atrioventricular nodal ablation in atrial fibrillation: a meta-analysis and systematic review. Circulation. Arrhythmia and electrophysiology 2012 Feb; 5; 1; 68-76; Chatterjee NA, Lewis GD What is the prognostic significance of pulmonary hypertension in heart failure? Circulation. Heart failure 2011 Sep; 4; 5; 541-5;